139 related articles for article (PubMed ID: 12817616)
1. Mesenchymal chondrosarcoma: molecular characterization by a proteomic approach, with morphogenic and therapeutic implications.
Brown RE; Boyle JL
Ann Clin Lab Sci; 2003; 33(2):131-41. PubMed ID: 12817616
[TBL] [Abstract][Full Text] [Related]
2. The Reed-Steinberg cell: molecular characterization by proteomic analysis with therapeutic implications.
Brown RE; Nazmi RK
Ann Clin Lab Sci; 2002; 32(4):339-51. PubMed ID: 12458885
[TBL] [Abstract][Full Text] [Related]
3. HER-2/neu-Positive breast carcinoma: molecular concomitants by proteomic analysis and their therapeutic implications.
Brown RE
Ann Clin Lab Sci; 2002; 32(1):12-21. PubMed ID: 11848612
[TBL] [Abstract][Full Text] [Related]
4. Morphoproteomic portrait of the mTOR pathway in mesenchymal chondrosarcoma.
Brown RE
Ann Clin Lab Sci; 2004; 34(4):397-9. PubMed ID: 15648779
[TBL] [Abstract][Full Text] [Related]
5. Screening for potential targets for therapy in mesenchymal, clear cell, and dedifferentiated chondrosarcoma reveals Bcl-2 family members and TGFβ as potential targets.
van Oosterwijk JG; Meijer D; van Ruler MA; van den Akker BE; Oosting J; Krenács T; Picci P; Flanagan AM; Liegl-Atzwanger B; Leithner A; Athanasou N; Daugaard S; Hogendoorn PC; Bovée JV
Am J Pathol; 2013 Apr; 182(4):1347-56. PubMed ID: 23415961
[TBL] [Abstract][Full Text] [Related]
6. [Clinicopathologic and immunohistochemical study of 23 cases of mesenchymal chondrosarcoma].
Pang ZG; He XZ; Wu LY; Wei W; Liu XY; Liao DY; Li FY; Zhang XL
Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):368-72. PubMed ID: 21914343
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathology analysis of mesenchymal chondrosarcoma in soft tissue].
Cai L; Gao ZF; Huang XY
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):501-5. PubMed ID: 17068623
[TBL] [Abstract][Full Text] [Related]
8. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases.
Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Rushing EJ
Hum Pathol; 2010 May; 41(5):653-62. PubMed ID: 20138330
[TBL] [Abstract][Full Text] [Related]
9. Immunoprofile of mesenchymal chondrosarcoma: aberrant desmin and EMA expression, retention of INI1, and negative estrogen receptor in 22 female-predominant central nervous system and musculoskeletal cases.
Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Santi M; Judkins AR; Rushing EJ
Ann Diagn Pathol; 2010 Feb; 14(1):8-14. PubMed ID: 20123451
[TBL] [Abstract][Full Text] [Related]
10. The use of Bcl-2 and PTHLH immunohistochemistry in the diagnosis of peripheral chondrosarcoma in a clinicopathological setting.
Hameetman L; Kok P; Eilers PH; Cleton-Jansen AM; Hogendoorn PC; Bovée JV
Virchows Arch; 2005 Apr; 446(4):430-7. PubMed ID: 15744499
[TBL] [Abstract][Full Text] [Related]
11. [Primary mesenchymal chondrosarcoma of the lung].
Geng J; Ding YQ; Liu LF; Zhu MG; Han HX; Cai JJ
Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):317-8. PubMed ID: 16181561
[No Abstract] [Full Text] [Related]
12. Mesenchymal chondrosarcoma of the rib: report of a case.
Aoki T; Watanabe M; Takagi K; Tanaka S; Aida S
Surg Today; 1996; 26(12):1020-3. PubMed ID: 9017968
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns.
Chatterton DE; Nguyen DN; Bering SB; Sangild PT
Int J Biochem Cell Biol; 2013 Aug; 45(8):1730-47. PubMed ID: 23660296
[TBL] [Abstract][Full Text] [Related]
14. Morphoproteomic and pharmacoproteomic correlates in hormone-receptor-negative breast carcinoma cell lines.
Brown RE; Lun M; Prichard JW; Blasick TM; Zhang PL
Ann Clin Lab Sci; 2004; 34(3):251-62. PubMed ID: 15487699
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of transforming growth factor-beta1 pretreatment on experimental pulmonary metastasis of MCS-1 Chinese hamster mesenchymal chondrosarcoma cells.
Fujisawa N; Sato NL; Motoyama TI
Tohoku J Exp Med; 1999 Mar; 187(3):203-13. PubMed ID: 10458477
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal chondrosarcoma: an immunohistochemical study of 10 cases examining prognostic significance of proliferative activity and cellular differentiation.
Nussbeck W; Neureiter D; Söder S; Inwards C; Aigner T
Pathology; 2004 Jun; 36(3):230-3. PubMed ID: 15203726
[TBL] [Abstract][Full Text] [Related]
17. NKX3.1 immunohistochemistry is highly specific for the diagnosis of mesenchymal chondrosarcomas: experience in the Australian population.
Ramanayake N; Vargas AC; Talbot J; Bonar F; Wong DD; Wong D; Mahar A; Karim R; Luk PP; Selinger C; Sioson L; Gill AJ; Maclean F
Pathology; 2021 Oct; 53(6):705-712. PubMed ID: 33640159
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults: experiences of the CWS and COSS study groups.
Dantonello TM; Int-Veen C; Leuschner I; Schuck A; Furtwaengler R; Claviez A; Schneider DT; Klingebiel T; Bielack SS; Koscielniak E; ;
Cancer; 2008 Jun; 112(11):2424-31. PubMed ID: 18438777
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571.
McGary EC; Weber K; Mills L; Doucet M; Lewis V; Lev DC; Fidler IJ; Bar-Eli M
Clin Cancer Res; 2002 Nov; 8(11):3584-91. PubMed ID: 12429650
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal chondrosarcoma of the thyroid -- a rare tumour at an unusual site.
Abbas M; Ajrawi T; Tungekar MF
APMIS; 2004 Jun; 112(6):384-9. PubMed ID: 15511276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
